 |
brivanib alaninate |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2011-03-18 00:00:00 |
| Sponsor | Bristol-Myers Squibb;P. O. Box 4000;Princeton, New Jersey, 08543 |
| |
brivanib alaninate |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2011-03-18 00:00:00 |
| Sponsor | Bristol-Myers Squibb;P. O. Box 4000;Princeton, New Jersey, 08543 |